Despite the differences between the sarcoma subtypes generated in the genetic and chemical carcinogenesis models, both studies demonstrate the contribution of the MEK5/ERK5 pathway to the pathophysiology of sarcoma. This evidence concerns the gene MAP2K5 and sarcoma.